Sodium Phenylacetate And Sodium Benzoate Injection, Solution, Concentrate
Product Images NDC 68475-001

4 FDA label images from Navinta Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sodium Phenylacetate And Sodium Benzoate (NDC 68475-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Navinta Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Ba395792 1598 42a7 8473 F7a677e40441 01)

Figure-1 (Ba395792 1598 42a7 8473 F7a677e40441 01)
Chemical structure diagram showing the molecular structures of Sodium Phenylacetate and Sodium Benzoate. The diagram depicts the arrangement of carbon, hydrogen, oxygen, and sodium atoms in each compound, consistent with their chemical identities.*
FDA Label Image

Figure-2 (Ba395792 1598 42a7 8473 F7a677e40441 02)

Figure-2 (Ba395792 1598 42a7 8473 F7a677e40441 02)
A biochemical pathway diagram illustrating the urea cycle and related reactions involving benzoate and phenylacetate metabolism. It shows labeled compounds such as glutamine, phenylacetate, hippurate, citrulline, and urea along with enzymes like CPS, OTC, ASS, ASL, ARG, and NAGS. The diagram highlights processes of urine excretion and the conversion of supplemented arginine with arrows indicating metabolic steps.*
FDA Label Image

Vial-label (Ba395792 1598 42a7 8473 F7a677e40441 03)

Vial-label (Ba395792 1598 42a7 8473 F7a677e40441 03)
Label for Sodium Phenylacetate and Sodium Benzoate Injection 10%/10% solution concentrate, 50 mL vial, for intravenous use only. The label includes dosage warnings, storage instructions, and states it is manufactured by Navinta LLC. It emphasizes administration through a central line to avoid burns and notes the solution must be diluted before IV use.*
FDA Label Image

Carton-label (Ba395792 1598 42a7 8473 F7a677e40441 04)

Carton-label (Ba395792 1598 42a7 8473 F7a677e40441 04)
Packaging label for Sodium Phenylacetate and Sodium Benzoate Injection, 10% / 10%, 50 mL vial. The label indicates the product is for intravenous use only, must be diluted before IV administration, and contains 100 mg/mL of each active ingredient. Manufactured by Navinta LLC. Storage instructions and warnings about administration through a central line are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.